We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Combination Gives ‘Exciting’ Results in Ovarian & Lung Cancer in Early Trial

News   Aug 22, 2018 | Original story from the Institute of Cancer Research

 
Drug Combination Gives ‘Exciting’ Results in Ovarian & Lung Cancer in Early Trial
 
 
 

RELATED ARTICLES

“Slug” Keeps Breast Stem Cell Health in Check

News

A transcription factor called "Slug" keeps breast cells healthy by regulating both stem cell activity and repair of DNA damage.

READ MORE

Removing Cancer Stem Cells’ "Invisibility Cloak"

News

Leukemia stem cells conceal themselves against the immune defense by suppressing a target molecule for natural killer cells.

READ MORE

Individual Genotypes May Determine Efficacy of Alzheimer's Disease Drugs

News

Researchers have determined that a human gene present in 75% of the population is a key reason why a class of drugs for Alzheimer's disease seemed promising in animal studies only to fail in human studies. In different Alzheimer's disease patients, different mechanisms may be at work that determine whether or not a given therapy will be effective.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE